Comunicato Stampa Ema su Xigris (drotrecogin alfa (attivato)
Disponibili on line importanti informazioni in merito al
ritiro dal commercio per mancanza di efficacia di Xigris (drotrecogin alfa (attivato)
Disponibili on line importanti informazioni in merito al
ritiro dal commercio per mancanza di efficacia di Xigris (drotrecogin alfa (attivato)
Disponibili on line importanti informazioni in merito al ritiro dal commercio per mancanza di efficacia di Xigris (drotrecogin alfa (attivato).
In a recent study, Xigris failed to show a survival benefit for patients with severe sepsis and septic shock.
Disponibili on line nuove ed importanti informazioni di sicurezza riguardanti l’importanza di valutare la funzionalità renale nei pazienti in trattamento con Pradaxa® (dabigatran etexilato).
L 'Agenzia Italiana del Farmaco rende disponibile on line la Nota
Informativa Importante che riporta nuove ed importanti raccomandazioni
relative all'utilizzo degli antidepressivi Seropram® / Elopram®
(Citalopram).
UPDATED 10/24/2011. Updated study data. Healthcare professionals should continue to monitor patients for neuropsychiatric symptoms.
We recently unveiled our new website, which was redesigned to better reflect your needs. The revised site reflects CADTH’s transformation, including updated content and a host of exciting new features. Now that you’ve had some time to navigate through our site, we thought it would be a good time to check back with you to see what you think. We value your feedback, please take five minutes to give us your input.
We recently unveiled our new website, which was redesigned to better reflect your needs. The revised site reflects CADTH’s transformation, including updated content and a host of exciting new features. Now that you’ve had some time to navigate through our site, we thought it would be a good time to check back with you to see what you think. We value your feedback, please take five minutes to give us your input.
Burkholderia cepacia bacteria may cause serious infection in individuals with a compromised immune system or chronic lung condition.
80.211.154.110